These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9102224

  • 21. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
    Kumar-Singh S, Segers K, Rodeck U, Backhovens H, Bogers J, Weyler J, Van Broeckhoven C, Van Marck E.
    J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
    [Abstract] [Full Text] [Related]

  • 22. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.
    Yang C, Romaniuk PJ.
    Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326
    [Abstract] [Full Text] [Related]

  • 23. Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
    Barbaux S, Niaudet P, Gubler MC, Grünfeld JP, Jaubert F, Kuttenn F, Fékété CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K.
    Nat Genet; 1997 Dec; 17(4):467-70. PubMed ID: 9398852
    [Abstract] [Full Text] [Related]

  • 24. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S, Royer-Pokora B.
    Oncogene; 1999 Apr 15; 18(15):2533-6. PubMed ID: 10229205
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
    Ladomery M, Sommerville J, Woolner S, Slight J, Hastie N.
    J Cell Sci; 2003 Apr 15; 116(Pt 8):1539-49. PubMed ID: 12640038
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.
    Sakamoto Y, Yoshida M, Semba K, Hunter T.
    Oncogene; 1997 Oct 23; 15(17):2001-12. PubMed ID: 9366517
    [Abstract] [Full Text] [Related]

  • 33. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
    Hewitt SM, Saunders GF.
    Anticancer Res; 1996 Oct 23; 16(2):621-6. PubMed ID: 8687106
    [Abstract] [Full Text] [Related]

  • 34. The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells.
    Sarfstein R, Werner H.
    J Neurochem; 2006 Nov 23; 99(3):818-26. PubMed ID: 16911581
    [Abstract] [Full Text] [Related]

  • 35. E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells.
    Maheswaran S, Englert C, Lee SB, Ezzel RM, Settleman J, Haber DA.
    Oncogene; 1998 Apr 23; 16(16):2041-50. PubMed ID: 9572485
    [Abstract] [Full Text] [Related]

  • 36. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program.
    Svedberg H, Chylicki K, Baldetorp B, Rauscher FJ, Gullberg U.
    Oncogene; 1998 Feb 19; 16(7):925-32. PubMed ID: 9484784
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
    Hewitt SM, Fraizer GC, Wu YJ, Rauscher FJ, Saunders GF.
    J Biol Chem; 1996 Apr 12; 271(15):8588-92. PubMed ID: 8621487
    [Abstract] [Full Text] [Related]

  • 39. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system.
    Wagner N, Wagner KD, Hammes A, Kirschner KM, Vidal VP, Schedl A, Scholz H.
    Development; 2005 Mar 12; 132(6):1327-36. PubMed ID: 15716344
    [Abstract] [Full Text] [Related]

  • 40. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
    Tajinda K, Carroll J, Roberts CT.
    Endocrinology; 1999 Oct 12; 140(10):4713-24. PubMed ID: 10499530
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.